There are about 100,000 people affected with thalassemia in Albania who need frequent blood transfusions, and roughly 3,000 teenagers die each year from this disease. Thalassemia is a blood disorder that hinders the ability to properly carry oxygen in the blood. Our goal is to assist Albanians who have thalassemia by hosting blood drives that will increase the blood bank reserves. We also hope to provide funds for clean and sterile equipment, needed medical supplies, and financial assistance. These transfusions will help avoid detrimental medical complications and provide better quality of life.
You can support the cause by donating below; any donation is much appreciated.
Albanian-Aid is a non-profit organization located in Florida. The primary focus of the organization is to aid individuals who suffer from thalassemia in Albania.
Thalassemia is an incurable, genetic disease in which the improper transport of red blood cells do not allow oxygen to circulate in the body. This leads to many extreme health complications.
Albanian-Aid strives to fundraise for those struggling with thalassemia in a country that is in desperate need of blood donations and medical supplies.
Please support our efforts to make an imperative difference in the lives of these individuals.
Currently, our project donations are assisting the Thalassemia Blood Bank in Lushnje, Albania. All proceeds directly benefit their blood bank and patients.
Thalassemia is an inherited disease passed from parents to their children. Those who suffer from thalassemia experience delayed growth, weakness, fatigue, and often osteoporosis. Thalassemia carriers often need to have their spleen removed because, since their bodies are constantly fighting infections, their spleen becomes enlarged and it can create further complications. The removal of the spleen can leave those who suffer from thalassemia more vulnerable to infections because the spleen is needed to help fight pathogens in the body. Infections are a major contributor to illnesses and they are the second most common cause of death in the world, hence why those who carry thalassemia remain so vulnerable.
The most common treatment for thalassemia is performing a blood transfusion. The blood transfusions process can last anywhere from one to four hours, and it entails receiving healthy blood from an individual with the same blood type. Due to the necessity of finding a blood donor with a a similar blood type, and the shortages that the blood banks are experiencing, those who suffer from thalassemia can often be left without treatment for their condition. Similarly, healthy blood cells live for about 120 days, meaning that those who receive the blood transfusions have a continual need for blood transfusions throughout their lives. Depending on the severity of the disease, some may even need blood transfusions every two to four weeks.